This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Eli Lilly and Company. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Shih-Ying Wu: Innovator in RNA Interference Agents
Introduction
Shih-Ying Wu is a prominent inventor based in Needham, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of RNA interference agents. Her innovative work has the potential to impact the treatment of various neurological conditions.
Latest Patents
Shih-Ying Wu holds a patent for MAPT RNA interference agents. This patent includes compositions comprising a MAPT RNAi agent and methods for using these agents to reduce MAPT expression and treat tauopathy in subjects. This groundbreaking work highlights her commitment to advancing medical science and improving patient outcomes.
Career Highlights
Wu is currently employed at Eli Lilly and Company, where she continues to push the boundaries of research and innovation. Her role at this leading pharmaceutical company allows her to collaborate with other experts in the field and contribute to the development of new therapeutic solutions.
Collaborations
Shih-Ying Wu has worked alongside notable colleagues, including Jibo Wang and Jeremy Schulenburg York. These collaborations have fostered a dynamic research environment that encourages the exchange of ideas and expertise.
Conclusion
Shih-Ying Wu's contributions to the field of RNA interference agents exemplify her dedication to innovation and improving healthcare. Her work at Eli Lilly and Company and her patent on MAPT RNAi agents underscore her role as a leading inventor in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile